Text
We read with great interest the recent article by Dr. Mahadevia and colleagues about altered systolic flow and aortopathy with bicuspid aortic valve (BAV), and the related editorial by Drs. Uretsky and Gillam.
1, 2 We are pleased that the hemodynamic parameter of flow displacement performed well. It showed the clearest differences between patients with BAVs and controls, and correlated with the prearch dilation seen in patients with right-noncoronary leaflet fusion.
1 Our experience with the parameter has been equally encouraging. It is easy to measure, shows excellent
reproducibility, and appears to correlate well with aortic growth in initial application. 3 We would like to point out, however, a technical difference between how Mahadevia et al. imaging. Yet as Michelena et al. report, patients who fit this profile -young patients without significant aortic or aortic valve disease -experience substantial morbidity. 4 The value of MR flow imaging may be to better risk stratify such patients through the early identification of abnormal flow that would otherwise go undetected by conventional imaging.
Not all patients with BAV have abnormal systolic flow, as Uretsky and Gillam discuss.
Instead, a range of leaflet abnormalities restrict normal systolic opening to varying degrees. 5 The more restricted the leaflet motion, the greater the deflection of flow from the vessel midline.
Furthermore, as small initial studies from Della Corte et al. and our group suggest, the greater the flow deflection (i.e., the greater the flow displacement), the faster the ascending aorta grows. 3, 5 An important similarity between these initial studies is the focus on young patients with minimal aortic and aortic valve disease. This cohort should feature prominently in the larger, longitudinal studies that Uretsky and Gillam allude to for more convincing assessment of the relationship between flow abnormalities and disease progression with BAV.
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